Biologics & Regulation
Navigating Biologics Regulation in a Changing Landscape
Key insights from the closed-door discussion on clinically efficient biosimilarity and the fireside chat with the US FDA team on the agency's evolving biosimilarity data requirements.
22 Jan 2026 · PDF · 12.0 MB